An Assessment of National Strategic Action Plans for Viral Hepatitis Elimination, 2016

An Assessment of National Strategic Action Plans for Viral Hepatitis Elimination, 2016–2021

Published:2023-09-13 Issue:Supplement_3 Volume:228 Page:S148-S153
ISSN:0022-1899
Container-title:The Journal of Infectious Diseases
language:en
Short-container-title:

Author:

Njuguna Henry N¹^ORCID,Hiebert Lindsey¹,Harris Angelique¹²,Morgan Rebecca L³⁴,Gupta Neil¹,Ward John W¹

Affiliation:

1. Coalition for Global Hepatitis Elimination, The Task Force for Global Health , Atlanta, Georgia , USA

2. Rollins School of Public Health , Atlanta, Georgia , USA

3. Department of Health Research Methods, Evidence and Impact, McMaster University , Hamilton, Ontario , Canada

4. School of Medicine, Case Western Reserve University , Cleveland, Ohio , USA

Abstract

Abstract In 2016, the World Health Organization (WHO) released the Global Health Sector Strategy (GHSS) setting goals for global hepatitis elimination. To inform new or revised viral hepatitis national strategic action plans (NSAPs) for 2022–2030, NSAPs developed during 2016–2021 were assessed for alignment with the WHO GHSS. Country NSAPs were assessed to determine if they included components in the 2016 GHSS. Of 55 country NSAPs, 19 (35%) did not include hepatitis B and C virus elimination goals, only 18 (33%) included targets for needles and syringes for persons who inject drugs, and 21 (38%) had a national budget or financing plan for hepatitis activities. Gaps identified indicate need for technical support in NSAP development.

Funder

Abbott Laboratories

AbbVie

Cepheid

Gilead Sciences

Merck

Pharco

Roche

Siemens

VBI Vaccines

Zydus-Cadila

Publisher